Drug Type Bispecific antibody |
Synonyms |
Target |
Action inhibitors, stimulants |
Mechanism BAK inhibitors(BCL2 antagonist/killer 1 inhibitors), DNA inhibitors(DNA inhibitors), Apoptosis regulatory proteins stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Discovery | Australia | - | |
| Breast Cancer | Discovery | Australia | - |






